140 related articles for article (PubMed ID: 16343739)
1. 11Beta-hydroxysteroid dehydrogenase type 1: purification from human liver and characterization as carbonyl reductase of xenobiotics.
Maser E; Wsol V; Martin HJ
Mol Cell Endocrinol; 2006 Mar; 248(1-2):34-7. PubMed ID: 16343739
[TBL] [Abstract][Full Text] [Related]
2. Purification, characterization and NNK carbonyl reductase activities of 11beta-hydroxysteroid dehydrogenase type 1 from human liver: enzyme cooperativity and significance in the detoxification of a tobacco-derived carcinogen.
Maser E; Friebertshäuser J; Völker B
Chem Biol Interact; 2003 Feb; 143-144():435-48. PubMed ID: 12604230
[TBL] [Abstract][Full Text] [Related]
3. Partial purification and characterization of a new human membrane-bound carbonyl reductase playing a role in the deactivation of the anticancer drug oracin.
Skarydová L; Skarka A; Novotná R; Zivná L; Martin HJ; Wsól V; Maser E
Toxicology; 2009 Oct; 264(1-2):52-60. PubMed ID: 19635524
[TBL] [Abstract][Full Text] [Related]
4. Biochemical properties of human dehydrogenase/reductase (SDR family) member 7.
Stambergova H; Skarydova L; Dunford JE; Wsol V
Chem Biol Interact; 2014 Jan; 207():52-7. PubMed ID: 24246760
[TBL] [Abstract][Full Text] [Related]
5. 11β-Hydroxysteroid dehydrogenase 1: Regeneration of active glucocorticoids is only part of the story.
Odermatt A; Klusonova P
J Steroid Biochem Mol Biol; 2015 Jul; 151():85-92. PubMed ID: 25151952
[TBL] [Abstract][Full Text] [Related]
6. The glucocorticoid-activating enzyme 11beta-hydroxysteroid dehydrogenase type 1 has broad substrate specificity: Physiological and toxicological considerations.
Odermatt A; Nashev LG
J Steroid Biochem Mol Biol; 2010 Mar; 119(1-2):1-13. PubMed ID: 20100573
[TBL] [Abstract][Full Text] [Related]
7. Role of type-1 11beta-hydroxysteroid dehydrogenase in detoxification processes.
Maser E; Oppermann UC
Eur J Biochem; 1997 Oct; 249(2):365-9. PubMed ID: 9370342
[TBL] [Abstract][Full Text] [Related]
8. 11Beta-hydroxysteroid dehydrogenase responsible for carbonyl reduction of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in mouse lung microsomes.
Maser E
Cancer Res; 1998 Jul; 58(14):2996-3003. PubMed ID: 9679962
[TBL] [Abstract][Full Text] [Related]
9. 11 beta-hydroxysteroid dehydrogenase mediates reductive metabolism of xenobiotic carbonyl compounds.
Maser E; Bannenberg G
Biochem Pharmacol; 1994 May; 47(10):1805-12. PubMed ID: 8204097
[TBL] [Abstract][Full Text] [Related]
10. Expression and NNK reducing activities of carbonyl reductase and 11beta-hydroxysteroid dehydrogenase type 1 in human lung.
Finckh C; Atalla A; Nagel G; Stinner B; Maser E
Chem Biol Interact; 2001 Jan; 130-132(1-3):761-73. PubMed ID: 11306092
[TBL] [Abstract][Full Text] [Related]
11. Enantioselectivity of carbonyl reduction of 4-methylnitrosamino-1-(3-pyridyl)-1-butanone by tissue fractions from human and rat and by enzymes isolated from human liver.
Breyer-Pfaff U; Martin HJ; Ernst M; Maser E
Drug Metab Dispos; 2004 Sep; 32(9):915-22. PubMed ID: 15319331
[TBL] [Abstract][Full Text] [Related]
12. Human microsomal carbonyl reducing enzymes in the metabolism of xenobiotics: well-known and promising members of the SDR superfamily.
Skarydová L; Wsól V
Drug Metab Rev; 2012 May; 44(2):173-91. PubMed ID: 22181347
[TBL] [Abstract][Full Text] [Related]
13. Carbonyl reduction of triadimefon by human and rodent 11β-hydroxysteroid dehydrogenase 1.
Meyer A; Vuorinen A; Zielinska AE; Da Cunha T; Strajhar P; Lavery GG; Schuster D; Odermatt A
Biochem Pharmacol; 2013 May; 85(9):1370-8. PubMed ID: 23419873
[TBL] [Abstract][Full Text] [Related]
14. Novel enzymological profiles of human 11beta-hydroxysteroid dehydrogenase type 1.
Hult M; Nobel CS; Abrahmsen L; Nicoll-Griffith DA; Jörnvall H; Oppermann UC
Chem Biol Interact; 2001 Jan; 130-132(1-3):805-14. PubMed ID: 11306096
[TBL] [Abstract][Full Text] [Related]
15. Human 11beta-hydroxysteroid dehydrogenase 1/carbonyl reductase: recombinant expression in the yeast Pichia pastoris and Escherichia coli.
Blum A; Martin HJ; Maser E
Toxicology; 2000 Apr; 144(1-3):113-20. PubMed ID: 10781878
[TBL] [Abstract][Full Text] [Related]
16. 11 Beta-hydroxysteroid dehydrogenase type 1 from human liver: dimerization and enzyme cooperativity support its postulated role as glucocorticoid reductase.
Maser E; Völker B; Friebertshäuser J
Biochemistry; 2002 Feb; 41(7):2459-65. PubMed ID: 11841241
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneity of 11beta-hydroxysteroid dehydrogenase type 1/microsomal carbonyl reductase (11beta-HSD/CR) in guinea pig tissues. Purification of the liver form suggests modification in the cosubstrate binding site.
Oppermann UC; Möbus E; Nagel G; Maser E
Toxicology; 2000 Apr; 144(1-3):63-9. PubMed ID: 10781872
[TBL] [Abstract][Full Text] [Related]
18. 7α-hydroxylation of dehydroepiandrosterone does not interfere with the activation of glucocorticoids by 11β-hydroxysteroid dehydrogenase in E(t)C cerebellar neurons.
Gottfried-Blackmore A; Jellinck PH; Vecchiarelli HA; Masheeb Z; Kaufmann M; McEwen BS; Bulloch K
J Steroid Biochem Mol Biol; 2013 Nov; 138():290-7. PubMed ID: 23851218
[TBL] [Abstract][Full Text] [Related]
19. 11beta-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response.
Tomlinson JW; Walker EA; Bujalska IJ; Draper N; Lavery GG; Cooper MS; Hewison M; Stewart PM
Endocr Rev; 2004 Oct; 25(5):831-66. PubMed ID: 15466942
[TBL] [Abstract][Full Text] [Related]
20. 11beta-hydroxysteroid dehydrogenase types 1 and 2: an important pharmacokinetic determinant for the activity of synthetic mineralo- and glucocorticoids.
Diederich S; Eigendorff E; Burkhardt P; Quinkler M; Bumke-Vogt C; Rochel M; Seidelmann D; Esperling P; Oelkers W; Bähr V
J Clin Endocrinol Metab; 2002 Dec; 87(12):5695-701. PubMed ID: 12466373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
